Stellate Ganglion Blockade: an Intervention for the Management of Ventricular Arrhythmias.
Autor: | Ganesh A; Duke Anesthesiology, Duke University, Durham, NC, USA., Qadri YJ; Emory Anesthesiology, Emory University, Atlanta, GA, USA., Boortz-Marx RL; Duke Anesthesiology, Duke University, Durham, NC, USA., Al-Khatib SM; Duke Cardiology, Duke University Medical Center, 2301 Erwin Road, Durham, NC, 27710, USA., Harpole DH Jr; Cardiothoracic Surgery, Duke University Medical Center, Durham, NC, USA., Katz JN; Duke Cardiology, Duke University Medical Center, 2301 Erwin Road, Durham, NC, 27710, USA., Koontz JI; Duke Cardiology, Duke University Medical Center, 2301 Erwin Road, Durham, NC, 27710, USA.; Duke Center for Atrial Fibrillation, Duke University Medical Center, Duke University, Durham, NC, USA., Mathew JP; Duke Anesthesiology, Duke University, Durham, NC, USA., Ray ND; Duke Anesthesiology, Duke University, Durham, NC, USA., Sun AY; Duke Cardiology, Duke University Medical Center, 2301 Erwin Road, Durham, NC, 27710, USA., Tong BC; Cardiothoracic Surgery, Duke University Medical Center, Durham, NC, USA., Ulloa L; Duke Anesthesiology, Duke University, Durham, NC, USA.; Center for Perioperative Organ Protection, Department of Anesthesiology, Duke University, Durham, NC, USA., Piccini JP; Duke Cardiology, Duke University Medical Center, 2301 Erwin Road, Durham, NC, 27710, USA.; Duke Clinical Research Institute, Durham, NC, USA.; Duke Center for Atrial Fibrillation, Duke University Medical Center, Duke University, Durham, NC, USA., Fudim M; Duke Cardiology, Duke University Medical Center, 2301 Erwin Road, Durham, NC, 27710, USA. marat.fudim@dm.duke.edu.; Duke Clinical Research Institute, Durham, NC, USA. marat.fudim@dm.duke.edu. |
---|---|
Jazyk: | angličtina |
Zdroj: | Current hypertension reports [Curr Hypertens Rep] 2020 Oct 23; Vol. 22 (12), pp. 100. Date of Electronic Publication: 2020 Oct 23. |
DOI: | 10.1007/s11906-020-01111-8 |
Abstrakt: | Purpose of Review: To highlight the indications, procedural considerations, and data supporting the use of stellate ganglion blockade (SGB) for management of refractory ventricular arrhythmias. Recent Findings: In patients with refractory ventricular arrhythmias, unilateral or bilateral SGB can reduce arrhythmia burden and defibrillation events for 24-72 h, allowing time for use of other therapies like catheter ablation, surgical sympathectomy, or heart transplantation. The efficacy of SGB appears to be consistent despite the type (monomorphic vs polymorphic) or etiology (ischemic vs non-ischemic cardiomyopathy) of the ventricular arrhythmia. Ultrasound-guided SGB is safe with low risk for complications, even when performed on anticoagulation. SGB is effective and safe and could be considered for patients with refractory ventricular arrhythmias. |
Databáze: | MEDLINE |
Externí odkaz: |